» Source: According to data from
Wolters Kluwer Health, Pharmaceutical Audit Suite,
January—September, 2007 |
Indication
EpiPen® and EpiPen® Jr (0.3 and 0.15 mg epinephrine) Auto-Injectors are indicated for emergency treatment of allergic reactions (anaphylaxis) for people with a history of an anaphylactic reaction.
Important Safety Information
EpiPen® Auto-Injectors should be used with extreme caution in people who have heart disease. Side effects of EpiPen® Auto-Injectors may include fast or irregular heartbeat, nausea, and breathing difficulty. Certain side effects may be increased if EpiPen® Auto-Injectors are used while taking tricyclic antidepressants or MAOIs.
The EpiPen® and EpiPen® Jr Auto-Injectors are designed as emergency supportive therapy only and are not a replacement or substitute for immediate medical or hospital care. In case of accidental injection, please seek immediate medical treatment.
© 2009 Dey, L.P., Napa, CA. All rights reserved. This Web site is intended for United States of America (U.S.A.) residents only and is subject to all applicable U.S.A. laws.
DEY®, EpiPen®, EpiPen® Jr, EpiPen 2-Pak®, and EpiPen Jr 2-Pak® are all registered trademarks of Dey, L.P.
Center for Anaphylactic Support™ is a trademark of Dey, L.P.
|
